Status:
COMPLETED
Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients
Lead Sponsor:
Thomas Jefferson University
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to assess the utility of "Acceptance and Commitment Therapy" (ACT) in which subjects learn new ways to manage uncomfortable experiences and feelings and to engage in posi...
Detailed Description
Patients will be consented in the adult cystic fibrosis clinic at Drexel University, Children's Hospital of Philadelphia, University of Pennsylvania Medical Center, St. Christopher's Hospital for Chil...
Eligibility Criteria
Inclusion
- Men and women aged 18 and above.
- Able to read/understand English.
- Diagnosis of cystic fibrosis.
- PHQ-9 score \> 4 or GAD-7 score \> 4.
Exclusion
- History of suicidal attempts or acute suicidal ideation on clinical assessment.
- Presence of psychotic disorder or symptoms.
- Pregnant women.
- Presence of psychiatric disorders that interfere with the participation of the study, judged by the study or treating clinician. Presence of other medical conditions that interfere with participation in the study, judged by the study or treating clinician.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT04114227
Start Date
July 1 2019
End Date
October 31 2023
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson Center City Clinic for Behavioral Medicine
Philadelphia, Pennsylvania, United States, 19107